Racial/Ethnic and Socioeconomic Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus in an Insured Population

BACKGROUND: The high cost of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) infection may present a barrier to access, thus contributing to disparities in treatment. However, few real-world data exist on factors associated with DAA uptake. METHODS: We conducted an observational st...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Marcus, Julia, Hurley, Leo, Chamberland, Scott, Champsi, Jamila, Gittleman, Laura, Korn, Daniel, Lai, Jennifer, Quesenberry, Charles, Ready, Joanna, Saxena, Varun, Seo, Suk, Witt, David, Silverberg, Michael
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631605/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.380
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares